Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats

Journal of Carcinogenesis

Volumn 4, Issue , 2005, Pages

  Mukherjee, Biswajit ^a   Ghosh, Shampa ^a   Das, Tanushree ^a   Doloi, Manika ^b  

^a JADAVPUR UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF HYGIENE AND PUBLIC HEALTH   (India)

Author keywords

Hepatic altered foci; Hepatocarcinogenesis; IGF II; mRNA; Rat

Indexed keywords

CYCLINE; DIETHYLNITROSAMINE; MESSENGER RNA; PHENOBARBITAL; SOMATOMEDIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SIZE; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; RAT;

EID: 26844566569     PISSN: 14773163     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-4-12     Document Type: Article

References (42)

1. Daughaday WH, Rotwein P: Insulin-like-growth factors I and II peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrinol Rev 1989, 10:68-91.
2. Rechler MM, Nissley SP: The nature and regulation of the receptors for insulin-like-growth factors. Ann Rev Physiol 1985, 47:425-442.
3. Brown AL, Graham DE, Nissley SP, Hill DJ, Strain AJ, Rechler MM: Developmental regulation of insulin like growth factor II mRNA in different rat tissues. J Biol Chem 1986, 261:445-462.
4. Humbel RE: Insulin like growth factor I and II. Eur J Bioche 1990, 190:445-462.
5. Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP, Ullrich A, Brechot C: Differential expression of insulin like growth factor II mRNA in human primary liver cancer, benign tumors and liver cirrhosis. Cancer Res 1998, 48:6844-6849.
6. Moses AC, Nissley SP, Short PA, Rechler MM, White RM, Knight AB, Higa OZ: Increased level of multiplication-stimulating activity or insulin-like-growth factor in fetal rat serum. Proc Natl Acad Sci USA 1998, 77:354-365.
7. Soares MB, Ishii DN, Efsratiadis A: Development and tissue specific expression of transcripts related to the rat insulin-like-growth factor II mRNA. Nucleic Acid Re 1985, 13:1119-1134.
8. Ueno T, Takahashi K, Tetsuya T, Matsuguchi T, Ikejiri K, Endo H, Yamamato M: Reactivation of rat insulin like growth factor II gene during hepatocarcinogenesis. Carcinogensis 1988, 9:1779-1783.
9. Li SL, Xu ZDX, Kimura G, Sun Y, Kawachi MH, Wilson TG, Wilczynk S, Yamaguchi YE: Expression of insulin like growth factor (IGF)-II in human prostate, breast, bladder and paraganglioma tumors. Cell Tissue Res 1998, 291:469-479.
10. Uchida K, Kondo M, Takeda S, Osada H, Takahashi T, Nakado A, Takahashi T: Altered transcriptional regulation of the insulin like growth factor 2 gene in human hepatocellular carcinoma. Mol Carcinogensis 1997, 18:193-198.
11. Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler C: Reactivation of insulin like growth factor II during hepato-carcinogensis in transgenic mice suggests a role of malignant growth. Cancer Res 1992, 52:2549-2556.
12. Stewart C, Rotwein P: Growth, differentiation and survival; multiple physiological functions for insulin like growth factors. Physiol Rev 1996, 76:1005-1026.
13. Cullen KJ, Smith HS, Hills, Lippman ME: Growth factor messenger RNA expression by human breast fibroblast from benign and malignant lesions. Cancer research 1991, 51:4978-85.
14. Zapf J, Schoenle E, Froeasch ER: Effect of insulin-like growth factor I and II: Some biological actions and receptors binding characteristics of two purified constituents of nonsuppressible insulin-like activity in human serum. Eur J Biochem 1978, 87:285-296.
15. Blatt J, White C, Dienes S, Friedman H, Foley T: Production of an insulin-like growth factor by osteosarcoma. Biochem Biophysics Res Commun 1984, 123:373-379.
16. Yang D, Rogler CE: Analysis of insulin-like growth factor II (IGF II) expression in neoplastic nodules and hepatocellular carcinoma of woodchucks utilizing in situ hybridization and immunohistochemistry. Carcinogenesis (Lond.) 1991, 12:1893-1901.
17. Modan-Moss D, Janicot M, Mclenithan JC, Lane MD, Casella SJ: Expression and Function of insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes. Biochem J 1998, 333:825-831.
18. Faber E: The sequential analysis of liver cancer induction. Biophys Biochim Acta 1980, 605:149-166.
19. Bannasch P, Zerban H, Hacker HJ: Foci of altered hepatocytes, rat. In Monogrpahs on pathology of laboratory animals. Digestive system Edited by: Jones TC, Popp J, Mohr U. Berlin, Heidelberg, New York; Tokyo, Springer; 1997:3-37.
20. Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P: Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 1997, 431:391-406.
21. Bannasch P: Pathogensis of hepatocellular carcinoma: sequential cellular, molecular and metabolic changes. In Progress in liver disease Volume 14. Edited by: Boyer JL, Ockner RK. Phildelphia, W.B. Saunders; 1996:1161-1197.
22. Fiorentino M, Grigioni WF, Baccarini P, Errico D, De Mitri MS, Pisi E, Mancini AM: Different in situ expression of insulin-like-growth factor type II in hepatocellular carcinoma: an in situ hybridization and immunohistochemical study. Diagn Mol Pathol 1994, 3:59-65.
23. Pence CB: Dietary Selenium and anti-oxidant status; toxic effects of 12 demethyl hydrazine in rats. J Nut 1991, 121:138-44.
24. Mukherjee B, Basu M, Chaterjee M: Effect of selenomethionine on N-methyl nitroso guanidine-induced colonic aberrant crypt foci in rats. Europian Journal of Cancer Prevention 2001, 10:347-355.
25. Bannasch P: The cytoplasm of hepatocytes during carcinogensis. In Recent Results in Cancer Research Volume 19. Heidelberg, Springer; 1968:1-10.
26. Bannasch P, Jahn UR, Hacker HJ, Hofmann W, Pichlmayr R, Otto G: Focal hepatic glycogenosis: a putative preneoplastic lesion associated with neoplasia and cirrhosis in explanted human livers. Int J of Oncology 1991, 10:261-268.
27. Yang D, Alt E, Rogler CE: Coordinate expression of N-myc2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatis virus carriers. Cancer Res 1993, 53:2020-7.
28. Moreno FS, Rizzi MBSL, Dagil MLA, et al.: Inhibitory effect of B-Carotene on preneoplastic lesions induced in Wiser rats by the resistant hepatocyte model. Carcinogenesis 1991, 12:1817-1822.
29. Braissant O, Wahli: A simplified in situ hydridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica 1998, 1:10-16.
30. Enzmann H, Zerban H, Kopp-Schneider A, Loser E, Bannasch P: Effects of low doses of N- Nitrosomorpholine on the development of early stages of hepatocarcinogenesis. Carcinogenesis 1995, 16:1513-1518.
31. Bannasch P, Blosch M, Zerban H: Spongiosis hepatis: Specific changes of the perisinusoidal liver cells induced in rats by N-Nitrosomorpholine. Lab Invest 1981, 44:252-264.
32. Stroebel P, Mayer F, Zerban H, Bannasch P: Neoplasm Deriving from the perisinusoidal (ito) cells in rat liver. Am J Path 1995, 146:903-913.
33. Amann G, Breitschopf H, Lassmann H, Suchanck Gm, Heniz-Erian P: Cellular localization of insulin- like growth factor II mRNA in human fetus and the placenta: detection with a digoxigenin labeled cRNA probe and immunocytochemistry. Pediatr Res 1998, 43:614-620.
34. Nivet V, Hajduch E, Hainault I, Delattre J, Lavau M, Hanique B: Sensitive northern blot by hybridization using digexigenin RNA probes for the mRNA detection of two gulcose transporter isoforms. Cell Mol Biol 1997, 41:979-984.
35. Sohda T, Oka Y, Iwata K, Gunn J, Kamimura S, Shijo H, Okumura M, Yun K: Co-localization of insulin-like growth factor II and the proliferation marker-MIBI in hepatocellular carcinoma cells. J Clin Pathol 1997, 50:135-137.
36. Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP, Allurich A, Brechot C: Differential expression of insulin-like-growth factor II mRNA in human primary liver cancers, benign tumors and liver cirrhosis. Cancer Res 1988, 48:6844-6849.
37. Norstedt GA, Levinewit A, Moller C, Eriksson LC, Andersson G: Expression of insulin-like-growth factor I (IGF I) and IGF II mRNA during hepatic development, proliferation and carcinogensis in rat. Carcinogensis 1988, 9:209-203.
38. Lin YZ, Ding L, Chen JY: Expression of IGF II and its relation to the differentiation of preneoplastic hepatocytes in rats. Chung-hua-Ping-Li-Hsuch-Tsa-Chih 1993, 22:9-12.
39. Chung CK, Antoniades HN: Expression of c-cis/platelet-derived growth factor β, insluin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemsitry. Cancer Res 1992, 52:3453-3459.
40. Wang YZ, Wong YC: Sex hormone-induced prostatic carcinogenesis in the noble rat: The role of insulin-like-growth factor-I (IGF I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Prostate 1998, 35:165-177.
41. Dietrich DR, Candrian R, Marsman DS, Popp JA, Kanfmann WK, Swenberg JA: Retrospective assessment of liver cell proliferation via PCA: a comparison with tritiated thymidine. Cancer Letter 1994, 79:45-51.
42. Aihara T, Noguchi S, Miyoshi Y, Sasaki Y, Nakamura Y, Monden M, Imaoka S: Allelic imbalance of insulin-like-growth factor II gene expression in cancer in cancerous and precancerous lesions of the liver. Hepatology 1998, 28:86-89